Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| 1 |
UnitedHealth
UNH
|
+$471M |
| 2 |
SW
Smurfit Westrock plc
SW
|
+$438M |
| 3 |
Walt Disney
DIS
|
+$409M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$363M |
| 5 |
Hewlett Packard
HPE
|
+$317M |
Top Sells
| 1 |
Apple
AAPL
|
+$700M |
| 2 |
Nike
NKE
|
+$609M |
| 3 |
Visa
V
|
+$544M |
| 4 |
Microchip Technology
MCHP
|
+$529M |
| 5 |
Becton Dickinson
BDX
|
+$501M |
Sector Composition
| 1 | Technology | 24.09% |
| 2 | Financials | 10.53% |
| 3 | Healthcare | 9.64% |
| 4 | Industrials | 8.43% |
| 5 | Consumer Discretionary | 7.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AXNX
3326
DELISTED
Axonics, Inc. Common Stock
AXNX
| $632K | ﹤0.01% |
9,068
-119
| -1% | -$8.3K |
|
3327
Sutro Biopharma
STRO
$76.1M
| $631K | ﹤0.01% |
182,226
+825
| +0.5% | +$2.86K |
|
3328
Elanco Animal Health
ELAN
$9.45B
| $629K | ﹤0.01% |
42,792
-725,494
| -94% | -$10.7M |
|
3329
Anika Therapeutics
ANIK
$127M
| $628K | ﹤0.01% |
25,430
-5,891
| -19% | -$146K |
|
|
ITOS
3330
DELISTED
iTeos Therapeutics
ITOS
| $628K | ﹤0.01% |
61,516
-17,953
| -23% | -$183K |
|
|
DESP
3331
DELISTED
Despegar.com
DESP
| $626K | ﹤0.01% |
50,485
-2,878
| -5% | -$35.7K |
|
3332
Centrus Energy
LEU
$4.79B
| $625K | ﹤0.01% |
11,394
-13,094
| -53% | -$718K |
|
|
DNB
3333
DELISTED
Dun & Bradstreet
DNB
| $624K | ﹤0.01% |
+54,232
| New | +$624K |
|
3334
Eventbrite
EB
$291M
| $620K | ﹤0.01% |
227,243
+171,868
| +310% | +$469K |
|
3335
Xeris Biopharma Holdings
XERS
$1.28B
| $619K | ﹤0.01% |
217,089
-2,817
| -1% | -$8.03K |
|
3336
United States 12 Month Oil Fund,
USL
$43.1M
| $616K | ﹤0.01% |
17,153
+3,319
| +24% | +$119K |
|
3337
Avidity Biosciences
RNA
$5.89B
| $612K | ﹤0.01% |
13,315
-26,729
| -67% | -$1.23M |
|
3338
SPDR MSCI USA Gender Diversity ETF
SHE
$276M
| $611K | ﹤0.01% |
5,392
+224
| +4% | +$25.4K |
|
|
EVM
3339
Eaton Vance California Municipal Bond Fund
EVM
$234M
| $609K | ﹤0.01% |
63,160
+38,272
| +154% | +$369K |
|
3340
Entrada Therapeutics
TRDA
$207M
| $609K | ﹤0.01% |
38,107
+24,560
| +181% | +$392K |
|
3341
Electromed
ELMD
$208M
| $606K | ﹤0.01% |
+28,211
| New | +$606K |
|
3342
Kyverna Therapeutics
KYTX
$213M
| $600K | ﹤0.01% |
122,777
+4,786
| +4% | +$23.4K |
|
|
NTST
3343
NETSTREIT Corp
NTST
$1.77B
| $600K | ﹤0.01% |
+36,296
| New | +$600K |
|
3344
iShares MSCI Hong Kong ETF
EWH
$725M
| $599K | ﹤0.01% |
32,110
-147,045
| -82% | -$2.74M |
|
3345
iShares Asia 50 ETF
AIA
$1.02B
| $599K | ﹤0.01% |
8,289
+114
| +1% | +$8.24K |
|
|
OPRA
3346
Opera Ltd
OPRA
$1.75B
| $597K | ﹤0.01% |
38,669
-29,973
| -44% | -$463K |
|
3347
Nature's Sunshine
NATR
$295M
| $597K | ﹤0.01% |
43,834
+997
| +2% | +$13.6K |
|
3348
WisdomTree US LargeCap Fund
EPS
$1.27B
| $597K | ﹤0.01% |
9,936
+694
| +8% | +$41.7K |
|
3349
First Trust Large Cap Growth AlphaDEX Fund
FTC
$1.28B
| $595K | ﹤0.01% |
4,528
-33
| -0.7% | -$4.34K |
|
3350
FlexShares Quality Dividend Defensive Index Fund
QDEF
$475M
| $592K | ﹤0.01% |
8,283
+1,321
| +19% | +$94.5K |
|